论文信息 - Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study. - 字舞流文

Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study.

I. Flinn | A. Ashkenazi | C. Cheah | G. Bray | J. Seymour | M. Fanale | D. Belada | S. Kelley | A. Kapp | S. Holden | A. Janíková | Myron S Czucman